Clinical study on the serum levels of thyroid stimulating hormone of patients with thyroid cancer

doi:10.3969/j.issn.1674-490X.2015.01.012

Abstract

Abstract: Objective To study the correlation between serum levels of thyroid stimulating hormone(TSH) and thyroid cancer. Methods A retrospective analysis of 200 case patients with thyroid disease were examined including sex, age, serum levels of thyroid stimulating hormone, pathological reports and other clinical date. Results The preoperative TSH level of patients with differentiated thyroid cancer were obviously higher than the patients with nodular goiter; the level of TSH in patients older than 60 with differentiated thyroid cancer increased significiently. Conclusion Preoperative TSH level can be used as an auxiliary diagnosis index of differentiated thyroid cancer.

Key words: thyroid stimulating hormone, nodular goiter, thyroid differentiated cancer

CLC Number:

R581

CHEN Na, JIN Xiaoshi, JIAO Zhengwei. Clinical study on the serum levels of thyroid stimulating hormone of patients with thyroid cancer[J]. Medical Reserch and Education, 2015, 32(1): 51-54.

References

[1] DAVIES L, WELCH H G. Increasing incidence of thyroid cancer in the United States, 1973-2002[J]. JAMA, 2006, 295(18): 2164-2167.
[2] CHEN A Y, JEMAL A, WARD E M, et al. Increasing incidence of diferentiated thyroid cancer in the United States, 1998-2005[J]. Cancer, 2009, 115(16): 3801-3807.
[3] BOELAERT K, HORACEK J, HOLDER R L, et al. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration[J]. J Clin Endocrinol Metab, 2006, 91(11): 4295-4301.
[4] KIM S S, LEE B J, LEE J C, et al. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extra thyroidal extension in Korean patients: a single-center experience[J]. Endocrine, 2011, 39(3): 259-265.
[5] GERSCHPACHER M, GOBL C, ANDERWALD C, et al. Thyrotropin serum concentrations in patients with papillary thyroid microcancers[J]. Thyroid, 2010, 20(4): 389-392.
[6] FIORE E, RAGO T, PROVENZALE M A, et al. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role[J]. Endocr Relat Cancer, 2009, 16(4): 1251-1260.
[7] 史良凤, 关海霞, 李玉姝, 等. 术前血清促甲状腺激素水平与甲状腺结节良恶性关系的研究[J]. 中华内分泌代谢杂志, 2010, 26(3): 213-214.
[8] 李建周, 金勇君, 刘欣, 等. 血清促甲状腺素水平与甲状腺癌发病的相关性[J]. 中华肿瘤杂志, 2011, 12(33): 921-924.
[9] 朱霞瑾. 血清促甲状腺激素水平与甲状腺癌的相关性[J]. 中国现代医生, 2012, 50(31): 11-13.
[10] POLYZOS S A, KITA M, EFSTATHIADOU Z, et al. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules[J]. J Cancer Res Clin Oncol, 2008, 134(9): 953-960.
[11] HEGEDUS L, BONNEMA S J, BENNEDBAEK F N. Management of simplenodular goiter: current status and future perspectives[J]. Endoer Rev, 2003, 24( 11): 102-132.
[12] 于炳旗, 张刚, 王晓春, 等. 甲状腺 75 例临床治疗分析[J]. 河北职工医学院学报, 2008, 25(4): 17-18.
[13] CHO M A, LEE M K, NAM K H, et al. Expression and role of estrogen receptor α and β in medullary thyroid carcinoma: different roles in cancer growth and apoptosis[J]. J Endocrinol, 2007, (195): 255-263.
[14] KUMAR A, KLINGE C M, GOLDSTEIN R E. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta[J]. Int J Oncol, 2010, 36(5): 1067-1080.
[15] RAPARIA K, MIN S K, MODY D R, et al. Clinical outcomes for“suspicious”category in thyroid fine-needle aspiration biopsy: Patient's sex and nodule size are possible predictors of malignancy[J]. Arch Pathol Lab Med, 2009, 133(17): 787-790.
[16] 王有菊, 史虹莉. 甲状腺激素和年龄相关性的研究[J]. 中国临床保健杂志, 2008, 2(11): 51-53.
[17] 于晓会, 单忠艳. 甲状腺结节的病因与流行病学趋势[J]. 中国预防医学杂志, 2013, 14(4): 194-204.